Company profile for CoreRx

NEW Drugs in Dev.: 1
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CoreRx™ is a contract pharmaceutical development organization that helps get you into the clinic faster, providing a complete spectrum of cGMP solutions for pharmaceutical dosage form development. Our wide range of support services, extensive instrumentation and rigorous quality systems provide timely results communicated in a clear, efficient and consistent manner. Pre-formulation & Analytical Development

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
CoreRx, Inc.14205 Myerlake Circle, Clearwater, FL 33760 USA
Telephone
Telephone
727.259.6950, 877.461.4448
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/corerx-societal-cdmo-and-bend-bioscience-unite-under-the-bend-bioscience-brand-to-provide-world-class-cdmo-offering-302237436.html

PR NEWSWIRE
04 Sep 2024

https://www.contractpharma.com/contents/view_breaking-news/2024-08-08/owen-murray-tapped-as-ceo-of-combined-bend-bioscience-corerx-and-societal-entities/?widget=listSection

CONTRACT PHARMA
08 Aug 2024

https://www.businesswire.com/news/home/20240806323592/en

BUSINESSWIRE
07 Aug 2024

https://www.contractpharma.com/contents/view_breaking-news/2024-04-09/corerx-completes-acquisition-of-societal-cdmo/

CONTRACTPHARMA
09 Apr 2024

https://www.globenewswire.com/news-release/2024/04/08/2859570/30326/en/CoreRx-Inc-Completes-Acquisition-of-Societal-CDMO-Inc.html

GLOBENEWSWIRE
08 Apr 2024
CoreRx moves to purchase Societal CDMO in $130M cash deal
CoreRx moves to purchase Societal CDMO in $130M cash deal

29 Feb 2024

// Fraiser Kansteiner FIERCE PHARMA

https://www.fiercepharma.com/pharma/private-manufacturer-corerx-strikes-130m-deal-snap-struggling-small-molecule-specialist

Fraiser Kansteiner FIERCE PHARMA
29 Feb 2024

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact CoreRx and get a quotation

CoreRx is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Dalda bulk offered by CoreRx

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty